Skip to main content

UBS Group AG

Position in AVTX — Avalo Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in AVTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$22,343,409
+$5,293,649 QoQ
Shares Held
1,209,059
+5.9% QoQ
Ownership
2.25%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 126 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. AVTX ranks #69 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AVTX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $22,343,409 1,209,059
2026-03-31 $17,049,760 1,141,980
2025-12-31 $8,677,138 477,816
2025-09-30 $574,592 45,208
2025-06-30 $417,781 83,724
2025-03-31 $792,597 98,951
2024-12-31 $731,995 98,519
2024-09-30 $58,273 6,134
2024-06-30 $44,678 3,583
2024-03-31 $167,757 7,713
2023-12-31 $18 2
2023-09-30 $13 112
2023-06-30 $680 1,919
2023-03-31 $4,111 2,350
2022-12-31 $31,131 6,177
2022-09-30 $22,442 6,760
2022-06-30 $4,261 8,526
2022-03-31 $16,231 22,390
2021-12-31 $30,249 17,794
2021-09-30 $106 49
2021-06-30 CERC 138
2021-03-31 CERC 13,533
2020-12-31 CERC 8,408
2020-09-30 CERC 3,574
2020-06-30 CERC 14,827
2020-03-31 CERC 23,203